resveratrol has been researched along with Cirrhosis, Liver in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (2.63) | 29.6817 |
| 2010's | 21 (55.26) | 24.3611 |
| 2020's | 16 (42.11) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, F; Tu, Y; Xu, X | 1 |
| Li, C; Zhan, Y; Zhang, R; Zheng, J | 1 |
| Li, J; Ma, Z; Qian, J; Sheng, L; Wang, Z; Wu, G; Zhang, Y | 1 |
| Haunschild, R; Marx, W | 1 |
| Dong, J; Hu, Y; Li, H; Li, Z; Liu, Y; Pan, Y; Wang, M; Yan, J | 1 |
| Gao, Y; Jiang, C; Li, J; Wang, C; Wang, H; Wang, Y; Yang, Y | 1 |
| Al-Ani, B; Dawood, AF; Ebrahim, HA; Ellatif, MA; Haidara, MA; Kamar, SS; Latif, NSA; ShamsEldeen, AM | 1 |
| Akdemir, AS; Anapali, M; Aydemir, D; Kaya-Dagistanli, F; Ozturk, M; Tanriverdi, G; Ulusu, NN; Ulutin, T; Uysal, O | 1 |
| Jiang, N; Ping, J; Xu, L; Zhang, J | 1 |
| Du, X; Li, H; Li, N; Li, Z; Mao, L; Niu, Y; Wang, L; Xu, W; Zhang, P | 1 |
| Cao, J; Chen, TT; Hu, Y; Liu, C; Peng, S; Shen, Y; Wang, Y; Xu, Y; Yin, J | 1 |
| Arab Sadeghabadi, Z; Goodarzi, MT; Karimi, J; Mohseni, R | 1 |
| Borojevic, R; Coelho, BP; Costa, BP; de Oliveira, CM; de Oliveira, JR; de Sousa, AC; Guma, FCR; Martins, LAM; Moraes, KDS; Vieira, MQ | 1 |
| Cheng, M; Mou, Q; Wang, Y; Zhu, L; Zhu, Z | 1 |
| Han, B; Li, S; Liu, Y; Lv, Y; Wang, X; Yu, H; Zhang, X; Zhang, Z; Zheng, X | 1 |
| Bai, Y; Han, S; He, S; Jiang, X; Li, X; Liang, Y; Lu, D; Luo, X; Peng, C; Sheng, R; Sun, S; Wang, Y; Wei, P; Yang, Z; Zhang, B | 1 |
| Al Humayed, S; Al-Ani, B; Ali Eshra, M; Attia, A; Badr, AM; Ebrahim, HA; Farag, AM; Haidara, MA; Kamar, SS; Rashed, L; ShamsEldeen, AM | 1 |
| Bautista-Pérez, R; Cano-Martínez, A; Carreón-Torres, E; Castrejón-Téllez, V; Díaz-Díaz, E; Flores-Estrada, J; Guarner-Lans, V; Pérez-Torres, I; Rubio-Ruíz, ME | 1 |
| Hajinejad, M; Kashani, IR; Mahmoudi, R; Mortezaee, K; Nekoonam, S; Omidi, A; Pasbakhsh, P | 1 |
| Bae, M; Lee, JY; Park, YK | 1 |
| Ahmad, A; Ahmad, R | 2 |
| Srinivas, BH; Sundhar, M; Vairappan, B | 1 |
| Cho, N; Kim, HP; Lee, PJ; Park, HJ | 1 |
| Chang, RL; Chen, RJ; Chen, TS; Day, CH; Huang, CY; Ju, DT; Lin, YC; Viswanadha, VP; Yao, CH; Yeh, YL | 1 |
| Hu, BL; Jiang, HX; Luo, W; Qin, QY; Qin, SY; Yu, B | 1 |
| Chen, Y; Xiao, Z | 1 |
| Barale, R; Bavaresco, L; Faliva, MA; Gerbi, V; Giacosa, A; La Vecchia, C; Negri, E; Opizzi, A; Perna, S; Pezzotti, M; Rondanelli, M | 1 |
| Ding, J; Fu, R; Hong, L; Sun, Q; Wu, J; Xu, T; Zhang, H | 1 |
| Jin, Q; Li, X; Lian, LH; Nan, JX; Sun, P; Wu, YL; Zhang, DQ; Zhang, Y; Zhang, YJ | 1 |
| Ahmad, FJ; Ahmad, I; Ahmad, S; Iqbal, Z; Singh, A | 1 |
| Cho, IJ; Cho, SS; Jang, CH; Ki, SH; Kim, KM; Kim, SJ; Shin, SM; Yang, JH | 1 |
| He, P; Lei, JH; Wang, CX; Yuan, WG; Zhang, CY | 1 |
| Lee, ES; Moon, JO; Shin, MO; Yoon, S | 1 |
| El-Agamy, DS; Said, SA; Shebl, AM | 1 |
| Chan, CC; Cheng, LY; Huang, YH; Lee, FY; Lin, CL; Lin, HC | 1 |
| Bosch, J; Di Pascoli, M; Diví, M; García-Pagán, JC; Gracia-Sancho, J; Rodríguez-Vilarrupla, A; Rosado, E; Vilaseca, M | 1 |
| Augé, N; Balabaud, C; Desmoulière, A; Godichaud, S; Nègre-Salvayre, A; Payrastre, B; Rosenbaum, J; Si-Tayeb, K | 1 |
4 review(s) available for resveratrol and Cirrhosis, Liver
| Article | Year |
|---|---|
A review of edible plant-derived natural compounds for the therapy of liver fibrosis.
Topics: Humans; Liver Cirrhosis; Phenols; Plants, Edible; Resveratrol | 2023 |
Food components with antifibrotic activity and implications in prevention of liver disease.
Topics: Blueberry Plants; Coffee; Curcumin; Food; Hepatic Stellate Cells; Hepatocytes; Humans; Liver Cirrhosis; Macrophages; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Resveratrol; Vitamins; Xanthophylls | 2018 |
Mediterranean Way of Drinking and Longevity.
Topics: Alcohol Drinking; Cardiovascular Diseases; Diet, Mediterranean; Female; Flavonols; Humans; Liver Cirrhosis; Longevity; Male; Mediterranean Region; Neoplasms; Phenols; Resveratrol; Risk Factors; Sex Factors; Sirtuins; Stilbenes; Wine | 2016 |
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
Topics: Acetyl-CoA C-Acetyltransferase; Animals; CD4-Positive T-Lymphocytes; Disease Progression; Fatty Liver, Alcoholic; Hepatic Stellate Cells; Humans; Interleukins; Intracellular Signaling Peptides and Proteins; LIM Domain Proteins; Liver Cirrhosis; Macrophages; MicroRNAs; Molecular Targeted Therapy; Non-alcoholic Fatty Liver Disease; Resveratrol; Schistosomiasis; Signal Transduction; Stilbenes; T-Lymphocytes, Regulatory; Triterpenes; Ursodeoxycholic Acid; Ursolic Acid; Virus Diseases | 2016 |
34 other study(ies) available for resveratrol and Cirrhosis, Liver
| Article | Year |
|---|---|
Resveratrol inhibited hepatocyte apoptosis and alleviated liver fibrosis through miR-190a-5p /HGF axis.
Topics: Animals; Apoptosis; Dose-Response Relationship, Drug; Hepatocyte Growth Factor; Hepatocytes; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Molecular Structure; Resveratrol; Structure-Activity Relationship | 2022 |
Resveratrol Inhibits Hepatic Stellate Cell Activation via the Hippo Pathway.
Topics: Animals; Apoptosis; Cell Proliferation; Cell Transdifferentiation; Cells, Cultured; Collagen; Hepatic Stellate Cells; Hippo Signaling Pathway; Humans; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Resveratrol; YAP-Signaling Proteins | 2021 |
Resveratrol Alleviates Hepatic Fibrosis in Associated with Decreased Endoplasmic Reticulum Stress-Mediated Apoptosis and Inflammation.
Topics: Animals; Apoptosis; Endoplasmic Reticulum Stress; Inflammation; Liver Cirrhosis; Rats; Resveratrol | 2022 |
On Health Effects of Resveratrol in Wine.
Topics: Beverages; Humans; Liver Cirrhosis; Resveratrol; Wine | 2022 |
Resveratrol ameliorates liver fibrosis induced by nonpathogenic Staphylococcus in BALB/c mice through inhibiting its growth.
Topics: Animals; In Situ Hybridization, Fluorescence; Liver Cirrhosis; Mice; Mice, Inbred BALB C; Resveratrol; Staphylococcus | 2022 |
Resveratrol ameliorates iron overload induced liver fibrosis in mice by regulating iron homeostasis.
Topics: Animals; Dextrans; Homeostasis; Iron; Iron Overload; Iron-Dextran Complex; Liver Cirrhosis; Mice; Resveratrol | 2022 |
Association of resveratrol with the suppression of TNF-α/NF-kB/iNOS/HIF-1α axis-mediated fibrosis and systemic hypertension in thioacetamide-induced liver injury.
Topics: Animals; Biomarkers; Chemical and Drug Induced Liver Injury, Chronic; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Liver; Liver Cirrhosis; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Resveratrol; Thioacetamide; Tumor Necrosis Factor-alpha | 2022 |
Combined resveratrol and vitamin D treatment ameliorate inflammation-related liver fibrosis, ER stress, and apoptosis in a high-fructose diet/streptozotocin-induced T2DM model.
Topics: Animals; Antioxidants; Apoptosis; Caspase 3; Diabetes Mellitus, Type 2; Diet; Endoplasmic Reticulum Stress; Fructose; Inflammation; Interleukin-6; Liver Cirrhosis; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Streptozocin; Tumor Necrosis Factor-alpha; Vitamin D | 2022 |
Resveratrol inhibits hepatic stellate cell activation by regulating autophagy and apoptosis through the SIRT1 and JNK signaling pathways.
Topics: Animals; Apoptosis; Autophagy; Hepatic Stellate Cells; Liver Cirrhosis; MAP Kinase Signaling System; Mice; Resveratrol; Sirtuin 1 | 2022 |
Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with
Topics: Actins; Animals; Collagen Type I; Collagen Type III; Liver Cirrhosis; Male; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Mitochondria; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Schistosoma japonicum; Schistosomiasis japonica | 2019 |
Co-administration of resveratrol and beta-aminopropionitrile attenuates liver fibrosis development via targeting lysyl oxidase in CCl
Topics: Aminopropionitrile; Animals; Carbon Tetrachloride Poisoning; Drug Delivery Systems; Liver Cirrhosis; Male; Protein-Lysine 6-Oxidase; Rats; Rats, Wistar; Resveratrol | 2019 |
Resveratrol increases the activation markers and changes the release of inflammatory cytokines of hepatic stellate cells.
Topics: Animals; Antioxidants; Cell Line; Cell Proliferation; Cytokines; Hepatic Stellate Cells; Inflammation; Liver Cirrhosis; Mice; Myofibroblasts; Resveratrol | 2021 |
Resveratrol contributes to the inhibition of liver fibrosis by inducing autophagy via the microRNA‑20a‑mediated activation of the PTEN/PI3K/AKT signaling pathway.
Topics: Animals; Autophagy; Base Sequence; Cell Line; Down-Regulation; Liver; Liver Cirrhosis; Male; MicroRNAs; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats, Sprague-Dawley; Resveratrol; Signal Transduction | 2020 |
Exploring the liver fibrosis induced by deltamethrin exposure in quails and elucidating the protective mechanism of resveratrol.
Topics: Animals; Chemical and Drug Induced Liver Injury; Humans; Insecticides; Liver Cirrhosis; NF-E2-Related Factor 2; NF-kappa B; Nitriles; Oxidative Stress; Protective Agents; Pyrethrins; Quail; Resveratrol; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1 | 2021 |
Sirtuin 1 ameliorates defenestration in hepatic sinusoidal endothelial cells during liver fibrosis via inhibiting stress-induced premature senescence.
Topics: Aging; Animals; Cellular Senescence; Endothelial Cells; Hepatocytes; Liver Cirrhosis; Oxidative Stress; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1 | 2021 |
Resveratrol suppresses cholestasis-induced liver injury and fibrosis in rats associated with the inhibition of TGFβ1-Smad3-miR21 axis and profibrogenic and hepatic injury biomarkers.
Topics: Acute Lung Injury; Animals; Antioxidants; Biomarkers; Cholestasis; Liver Cirrhosis; Male; MicroRNAs; Rats; Rats, Wistar; Resveratrol; Smad3 Protein; Transforming Growth Factor beta1 | 2021 |
Resveratrol and Quercetin as Regulators of Inflammatory and Purinergic Receptors to Attenuate Liver Damage Associated to Metabolic Syndrome.
Topics: Animals; Antioxidants; Cytokines; Gene Expression Regulation; Inflammation; Liver Cirrhosis; Male; Metabolic Syndrome; Quercetin; Rats; Rats, Wistar; Receptors, Purinergic; Resveratrol | 2021 |
Resveratrol pretreatment enhanced homing of SDF-1α-preconditioned bone marrow-derived mesenchymal stem cells in a rat model of liver cirrhosis.
Topics: Animals; Bone Marrow Cells; Chemokine CXCL12; Disease Models, Animal; Graft Enhancement, Immunologic; Liver Cirrhosis; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2018 |
Proteomic approach to identify molecular signatures during experimental hepatic fibrosis and resveratrol supplementation.
Topics: Amino Acid Sequence; Animals; Biomarkers; Liver; Liver Cirrhosis; Male; Proteomics; Rats; Resveratrol | 2018 |
Resveratrol Restores Neuronal Tight Junction Proteins Through Correction of Ammonia and Inflammation in CCl
Topics: Aldehydes; Ammonia; Animals; Brain; Carbon Tetrachloride; Cytokines; Inflammation; Liver Cirrhosis; Male; Mice; Models, Biological; Neurons; NF-kappa B; Nitric Oxide Synthase Type II; Occludin; Oxidative Stress; Resveratrol; Tight Junction Proteins; Water; Zonula Occludens-1 Protein | 2019 |
3,5-Diethoxy-3'-Hydroxyresveratrol (DEHR) Ameliorates Liver Fibrosis via Caveolin-1 Activation in Hepatic Stellate Cells and in a Mouse Model of Bile Duct Ligation Injury.
Topics: Animals; Apoptosis; Bile Ducts; Caveolin 1; Collagen; Disease Models, Animal; Gene Expression Regulation; Heme Oxygenase-1; Hepatic Stellate Cells; Humans; Ligation; Liver; Liver Cirrhosis; Membrane Proteins; Mice; Resveratrol; Signal Transduction; Transcriptional Activation | 2018 |
Protective effect of autologous transplantation of resveratrol preconditioned adipose-derived stem cells in the treatment of diabetic liver dysfunction in rat model.
Topics: Adipose Tissue; Animals; Apoptosis; Cell Survival; Clone Cells; Culture Media, Conditioned; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose; Liver; Liver Cirrhosis; Liver Diseases; Male; Protective Agents; Rats, Wistar; Resveratrol; Signal Transduction; Sirtuin 1; Stem Cell Transplantation; Stem Cells; Tissue Survival; Transplantation, Autologous | 2019 |
Resveratrol improves CCL4-induced liver fibrosis in mouse by upregulating endogenous IL-10 to reprogramme macrophages phenotype from M(LPS) to M(IL-4).
Topics: Animals; Carbon Tetrachloride; Cell Polarity; Inflammation; Interleukin-10; Interleukin-4; Kupffer Cells; Lipopolysaccharides; Liver Cirrhosis; Macrophages; Male; Mice; Mice, Inbred BALB C; Phenotype; RAW 264.7 Cells; Resveratrol; Up-Regulation | 2019 |
[Therapeutic effect of resveratrol as well as resveratrol combined with praziquantel on the liver fibrosis due to Schistosoma japonicum infection in mice].
Topics: Animals; Drug Therapy, Combination; Female; Liver Cirrhosis; Male; Mice; Oxidative Stress; Praziquantel; Resveratrol; Schistosoma japonicum; Schistosomiasis japonica; Stilbenes; Vascular Endothelial Growth Factor A | 2013 |
Resveratrol mitigate structural changes and hepatic stellate cell activation in N'-nitrosodimethylamine-induced liver fibrosis via restraining oxidative damage.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Dimethylnitrosamine; Electrophoresis, Gel, Two-Dimensional; Hepatic Stellate Cells; Liver Cirrhosis; Male; Oxidative Stress; Rats; Resveratrol; Stilbenes | 2014 |
Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-κB pathways.
Topics: Actins; Animals; Biomarkers; Cell Line; Disease Models, Animal; Disease Progression; Enzyme Activation; Humans; Liver Cirrhosis; Male; Mice, Inbred C57BL; NF-kappa B; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes | 2016 |
Resveratrol Regulates Activated Hepatic Stellate Cells by Modulating NF-κB and the PI3K/Akt Signaling Pathway.
Topics: Actins; Animals; Cell Line; Cell Survival; Collagen; Hepatic Stellate Cells; Lipopolysaccharides; Liver; Liver Cirrhosis; Myeloid Differentiation Factor 88; NF-kappa B; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phosphorylation; Phytotherapy; Plant Extracts; Protein Serine-Threonine Kinases; Rats; Resveratrol; Signal Transduction; Stilbenes; Toll-Like Receptor 4 | 2016 |
A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics.
Topics: Administration, Oral; Animals; Biological Availability; Biomarkers; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Stability; Lipids; Liver; Liver Cirrhosis; Male; Nanoparticles; Particle Size; Protective Agents; Rats; Rats, Wistar; Resveratrol; Stilbenes; Suspensions; X-Ray Diffraction | 2016 |
The Role of Lipin-1 in the Regulation of Fibrogenesis and TGF-β Signaling in Hepatic Stellate Cells.
Topics: Cell Line, Transformed; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Phosphatidate Phosphatase; Resveratrol; Signal Transduction; Stilbenes; Transforming Growth Factor beta | 2016 |
Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
Topics: Alkylating Agents; Animals; Antioxidants; Biomarkers; Chemical and Drug Induced Liver Injury, Chronic; Dimethylnitrosamine; Down-Regulation; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Male; Organ Size; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes; Transforming Growth Factor beta1; Weight Loss | 2010 |
Prevention and treatment of Schistosoma mansoni-induced liver fibrosis in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Benzamides; Bilirubin; Curcumin; Hydroxyproline; Imatinib Mesylate; Liver; Liver Cirrhosis; Male; Mice; Piperazines; Pyrimidines; Resveratrol; Schistosoma mansoni; Schistosomiasis mansoni; Serum Albumin; Stilbenes | 2011 |
The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury.
Topics: Aldehydes; Animals; Bile Ducts; Cell Proliferation; Cholestasis; Collagen Type I; Hepatocytes; Inflammation; Interleukin-6; Kupffer Cells; Ligation; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Resveratrol; RNA, Messenger; Stilbenes; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha | 2011 |
Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Topics: Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension, Portal; Liver; Liver Cirrhosis; Liver Cirrhosis, Experimental; Male; Nitric Oxide Synthase Type III; Portal Pressure; Rats; Rats, Wistar; Resveratrol; Stilbenes; Thromboxane A2 | 2013 |
The grape-derived polyphenol resveratrol differentially affects epidermal and platelet-derived growth factor signaling in human liver myofibroblasts.
Topics: Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Fibroblast Growth Factors; Fibroblasts; Flavonoids; Humans; Liver; Liver Cirrhosis; Myoblasts; Phenols; Platelet-Derived Growth Factor; Polyphenols; Resveratrol; Signal Transduction; Stilbenes; Vitis | 2006 |